News

Insights into the fundamental process of how the heart is formed offer new hope for treating heart disease. The findings focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.

Machine learning can predict which adolescents with HIV will be less likely to adhere to therapy. With such knowledge, healthcare practitioners could implement interventions for those identified as less likely to adhere to the treatment plan.

Scientists at St. Jude Children’s Research Hospital have found that frequently used antivirals do not work well against the H5N1 avian influenza virus in cows’ milk.

A National Institutes of Health (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

Researchers have developed a new method for the rapid scalable preparation of uniform nanostructures directly from block polymers.

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

Researchers from the Institute of Science Tokyo have developed CeSPIACE, a peptide inhibitor that blocks SARS-CoV-2 from binding to host cell receptors. Unlike some existing treatments, CeSPIACE works against many variants.

Researchers have developed a compound that could potentially treat the autoimmune disorder alopecia, which causes hair loss leading to the formation of bald patches.

Avapritinib, an FDA-approved drug used to treat other types of cancer, also decreases aggressive gliomas in animal models and in an initial cohort of patients with high-grade glioma.

Studying how proteins cluster and organize themselves at the cell membrane could pave the way for innovative cystic fibrosis treatments.